Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
3
×
rna interference
san francisco blog main
san francisco top stories
arrowhead pharmaceuticals
biotech
boston
deals
eli lilly
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
nobel prize
pfizer
san diego blog main
san diego top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
agency
akcea therapeutics
akili interactive labs
alexion pharmaceuticals
alicia hager
alnylam pharmaceutials
alnylam pharmaceuticals
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
andrew fire
arca biopharma
What
rnai
3
×
gets
abandoning
afternoon
ago
alliance
alnylam
alnylam’s
approved
baggage
bio
bristol
buy
calls
changing
color
companies
crispr
cuts
days
deal
development
dicerna
drug
fda
free
growing
history
hours
interference
kudos
landmark
leaves
long
making
medicine
medicines
myers’s
notifying
october
Language
unset
Current search:
rnai
×
" national top stories "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug